These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 24636278)
1. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases. Allard MA; Malka D J Visc Surg; 2014 Apr; 151 Suppl 1():S21-4. PubMed ID: 24636278 [TBL] [Abstract][Full Text] [Related]
2. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274 [TBL] [Abstract][Full Text] [Related]
3. Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer? Goldberg RM Semin Oncol; 1998 Oct; 25(5 Suppl 11):21-8. PubMed ID: 9786313 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746 [TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315 [TBL] [Abstract][Full Text] [Related]
6. [Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumors]. Lorenz M; Hottenrott C; Encke A Zentralbl Chir; 1993; 118(5):279-89. PubMed ID: 8322538 [TBL] [Abstract][Full Text] [Related]
7. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792 [TBL] [Abstract][Full Text] [Related]
8. [Hepatic arterial infusion after hepatectomy for liver metastases of colorectal carcinoma to prevent residual hepatic recurrence]. Takahashi K; Mori T; Takahashi T Gan To Kagaku Ryoho; 1994 Sep; 21(13):2165-8. PubMed ID: 7944430 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211 [TBL] [Abstract][Full Text] [Related]
10. [Hepatic metastases of colorectal cancers: intra-arterial chemotherapy. Value and indications]. Rougier P; Ducreux M; Elias D; Lasser P Presse Med; 1996 Nov; 25(35):1683-8. PubMed ID: 8977580 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. Kemeny N; Conti JA; Cohen A; Campana P; Huang Y; Shi WJ; Botet J; Pulliam S; Bertino JR J Clin Oncol; 1994 Nov; 12(11):2288-95. PubMed ID: 7964942 [TBL] [Abstract][Full Text] [Related]
12. INTRA-ARTERIAL CHEMOTHERAPY AS A CLINICAL OPTION FOR METASTATIC COLORECTAL CANCER: CONVERSION OF INOPERABLE LIVER METASTASES TO OPERABLE ILLUSTRATED WITH A CLINICAL CASE. Cherchenko K; Lukashenko A; Ostapenko Y; Patsko V; Vinohradova M; Valikhnovska K; Pamanska S Exp Oncol; 2024 Feb; 45(4):515-522. PubMed ID: 38328838 [TBL] [Abstract][Full Text] [Related]
13. Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: an alternative to FUdR-based regimens? Cosimelli M; Mannella E; Anzá M; Civalleri D; Balletto N; Di Tora P; Durante F; Porcellana M; Cavaliere P; Anfossi A J Surg Oncol Suppl; 1991; 2():63-8. PubMed ID: 1832541 [No Abstract] [Full Text] [Related]
14. Hepatic artery chemotherapy for colorectal liver metastases. McCall JL; Jorgensen JO; Morris DL Aust N Z J Surg; 1995 Jun; 65(6):383-9. PubMed ID: 7786259 [TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Stagg RJ; Lewis BJ; Friedman MA; Ignoffo RJ; Hohn DC Ann Intern Med; 1984 May; 100(5):736-43. PubMed ID: 6231876 [TBL] [Abstract][Full Text] [Related]
16. Arterial chemotherapy in the management of colorectal cancer: an overview. Patt YZ; Mavligit GM Semin Oncol; 1991 Oct; 18(5):478-90. PubMed ID: 1925634 [TBL] [Abstract][Full Text] [Related]
17. Treatment of colorectal cancer with unresectable synchronous liver-only metastases with combined therapeutic modalities. Cui Y; Li H; Wu Q; Zhang T; Kong D; Song T; Ru T; Chen P; Li Q J Gastrointest Surg; 2011 Feb; 15(2):285-93. PubMed ID: 20922574 [TBL] [Abstract][Full Text] [Related]